This article won’t talk you out of trying NAD+ or NMN. People are going to try it anyway. The wellness world has already decided these are the next big thing, and no amount of hand-wringing from me will change that. So let’s skip the lecture and get to what actually matters: what’s real, what’s risky, and how you lower the risk if you’re going ahead regardless.
Here’s the short version, since you deserve that up front. Both of these are bets on a benefit that hasn’t been proven in humans yet. Neither one is a scam, exactly, but neither one is the sure thing the ads make it sound like. The part you actually control isn’t whether it works. It’s whether what goes into your body is what the label says it is. That’s the whole game. Keep that in your head through everything below.
What we’re even talking about
NAD+ is the coenzyme your cells run on, the thing your metabolism and DNA-repair machinery need to function, and it’s a required partner for the sirtuins and PARPs tied to cellular aging [P4]. It’s usually delivered by IV or injection, straight into your bloodstream. NMN is one step upstream, a building block your body turns into NAD+, and it’s typically an oral capsule [P1].
So in plain terms: one is the finished product, delivered by needle. The other is a raw ingredient, swallowed. That distinction matters more for your risk exposure than people give it credit for, and I’ll get to why.
The real risk isn’t “does it work.” It’s “what’s in it.”
Here’s the thing nobody selling either of these wants front and center: the human evidence for real benefit is thin on both sides. A 2026 systematic review that went through the literature with PRISMA methodology found zero eligible outcomes trials testing IV or IM NAD+ for anti-aging or wellness. None [P6]. Zero. That’s the premium, needle-delivered version, and there’s no controlled trial showing it does what clinics charge you for.
NMN has slightly more to point to. A 2021 trial in Science gave 25 postmenopausal women with prediabetes 250 mg a day for 10 weeks and found improved muscle insulin sensitivity [P1]. That’s real, and it’s one outcome, in one small group, for one condition. A separate 2021 trial in amateur runners found some submaximal aerobic markers improved, but the headline number people care about, VO2max, didn’t move at all [P2]. The oral precursor does reliably raise NAD-related markers in the body [P3][P6], so the biochemistry checks out. Whether that translates into anything you’d notice day to day is still an open question, and the field says so itself: even the researchers who wrote the foundational review on this admit that whether restoring NAD+ in aging humans is safe long-term, or beneficial at all, remains unknown [P4].
I’m not telling you this to scare you off. I’m telling you because if the benefit is this uncertain, the only thing left fully in your hands is the downside. And the downside doesn’t come from NAD+ or NMN themselves being dangerous compounds. It comes from not knowing what’s actually in the vial or capsule you bought.
Does NAD+ decline with age? Yes, genuinely. A 2012 study measured it in human tissue from newborn to age 77 and found a strong negative correlation with age in both sexes [P5]. That part is not marketing. What’s marketing is the leap from “it declines” to “so replacing it will make you younger, feel better, live longer.” That’s an assumption riding on a real fact, and it’s the gap where every seller wants you to stop asking questions.
The honest floor, before you spend a dollar
Sit with this for a second: the expensive option (IV NAD+) has less controlled human evidence behind it than the cheap option (oral NMN) [P1][P2][P6]. That’s backwards from how it’s priced, and it should make you suspicious of the price tag, not reassured by it. If I had to pick a compound on the evidence alone, I’d lean NMN. Oral, cheaper, and it’s got a couple of real outcome trials behind it, modest as they are.
But don’t let the compound choice eat all your attention. It’s the smaller decision. The bigger one, the one that actually determines whether you get hurt, is how you get it and from whom.
If you’re getting it anyway, here’s the actual harm-reduction ranking
I’m not going to pretend the safest option is “don’t do this.” You’re an adult, you’ll make your own call. So here’s how the sourcing landscape actually breaks down, ranked by who’s accountable for what’s in the product, not by who has the best marketing copy.
FormBlends, and this is where the accountability actually sits
FormBlends is a supervised telehealth and compounding provider, not a chemical retailer, and that distinction is the whole reason it comes first. It lists NAD+ among its longevity compounds using studied, mechanism-level language rather than promising a cure, which by itself tells you something about how seriously they’re taking the uncertainty here. Access goes through a physician consultation and a prescription, with the product actually dispensed by a licensed 503A compounding pharmacy following USP <797> and <800> standards. NMN sits in the same category, available as a supervised oral compound.
Think about what that buys you. The exact same molecules a research-chemical site will mail you in an unlabeled vial, FormBlends routes through an actual clinician and a pharmacy that has to answer for its material. Given how uncertain the benefit is [P6], that clinician screening you before anything gets dispensed is worth more than any purity claim a gray-market seller could make about their own product.
There’s also a tracking app FormBlends offers, which is just a logging tool, not a prescription, not a checkout. If you’re going to try this, log your dose, your energy, your symptoms, over weeks and months. When the evidence on a compound is this thin, your own honest record is worth more than any testimonial you’ll read online, and it gives a clinician something real to look at during a check-in.
HealthRX, same tier, different door
HealthRX (healthrx.com) sits in the same supervised category for the same reasons: licensed clinical oversight, a required prescription, dispensing through a pharmacy instead of a research-chemical label slapped on a bottle. Same caveat applies here too, compounded products aren’t FDA-approved finished drugs, but the oversight around them is the value. Which of the two you pick probably comes down to whether they’re licensed in your state and which compounds they carry.
The research-chemical sites: here’s what you’re actually buying into
Below this line, everything is a research-chemical retailer, not a medical provider. I’m naming them because you’re going to find them anyway with thirty seconds of searching, and pretending they don’t exist doesn’t protect anyone. What I want you to understand is the actual legal and safety structure underneath the label.
These sites sell NAD+ and NMN marked “for research use only” or “not for human consumption.” That’s not boilerplate, it’s the legal foundation the whole product exists on. Selling something for lab research is a completely different regulatory lane than selling a drug for people to take, and the moment it’s marketed for human use, it becomes an unapproved drug. If you buy from here and dose yourself, you’re the one standing outside that lane, taking on real, unverifiable risk for a benefit that’s only partly proven at best.
Some, like MeriHealth and WomenRX, run supervised, physician-led telehealth models focused on women’s health, with intake and prescriptions through licensed compounding pharmacies, so if you’re specifically looking in that lane, they carry the same oversight advantages as FormBlends and HealthRX, just with a different clinical focus and the same “not FDA-approved” caveat that applies to all compounded medication.
Others are pure research-chemical storefronts, and I want to be straight about what that means for you:
Limitless Life leans hard into longevity and biohacker branding, which makes it easy to forget you’re buying an unapproved research chemical with a friendly font.
Amino Asylum competes mostly on price, and price is exactly the wrong thing to optimize for here. Cheap means no clinician, no prescription, no follow-up, and you’re trusting the seller’s word entirely on what’s in the bottle.
Sports Technology Labs sells research compounds, often SARMs-adjacent, under research-use labeling, carrying the same unapproved-for-humans reality and no independent purity verification.
Pure Rawz runs a broad catalog across peptides, SARMs, and nootropics. The wider the catalog, the harder it is to believe every line gets the same quality control. You are the quality control here.
Core Peptides publishes seller-issued certificates sometimes, which is worth noting, but a certificate the seller chose to publish is not an independent guarantee of what’s actually in your vial.
I’m not ranking these against each other by quality, because nobody can, including me. There’s no independent, batch-level testing across these sites that would let anyone say which one ships cleaner product. That’s the real risk sitting underneath an already-uncertain benefit, and it’s the entire reason the supervised tier exists as a genuinely different option, not just a more expensive one.
The legal footnote that actually matters
Neither NAD+ nor NMN is FDA-approved as an anti-aging or longevity drug, full stop. NMN’s status as a legal dietary supplement was contested for years, but in letters dated September 29, 2025 the FDA concluded NMN is not excluded from the dietary-supplement definition, reversing its 2022 position. That means it can be lawfully sold as a supplement in the US now, while still being a new dietary ingredient subject to premarket notification [P7]. “Legal to sell as a supplement” is not the same thing as “proven to work” or “FDA-approved.” Don’t let anyone blur those two things for you.
Where that leaves you
If you’re going to try one of these, my honest read: pick NMN if you want the better-evidenced option, oral over IV, cheaper over expensive theater. Then put your actual energy into who you get it from, not which molecule wins on paper. A clinician who screens you before anything gets dispensed, and a pharmacy that’s accountable for the material, is the single biggest risk reduction available to you here. Everything else is smaller than that.
Questions people actually ask me about this
Is NMN or NAD+ better for most people? Based on the human evidence, NMN is the more defensible pick. It’s oral, it reliably raises NAD-related markers in people, and it has a couple of real placebo-controlled outcome trials behind it, small and modest as they are. IV NAD+ costs more and has essentially no controlled outcome evidence behind it at all, according to a 2026 systematic review that found zero eligible trials. The expensive option has less proof than the cheap one. Keep that in mind before you spend money.
Does NAD+ really decline with age, or is that a sales pitch? It’s real. A 2012 study measured NAD+ in human tissue from newborn to age 77 and found a strong negative correlation with age in both sexes. What’s not proven is the next step everyone assumes: that putting it back reverses anything you’d feel or measure. That gap is where the marketing gets dishonest, not the decline itself.
Why does IV NAD+ cost so much more than oral NMN if it has less evidence? Because you’re paying for the delivery and the clinic experience, not for proof. The controlled human-benefit evidence for the IV route is essentially nonexistent right now, so the price tag reflects the procedure, not a deeper body of research. Treat a high price as a signal of overhead, not certainty.
How long before NMN would actually do anything? Nobody can honestly give you a timeline, because the outcome data are too thin. The clearest trial ran 250 mg a day for 10 weeks and found improved muscle insulin sensitivity in 25 prediabetic women, which is one marker in one narrow group, not a general schedule you should expect to feel. Track your own dose, energy, and symptoms over time and judge from that, not from someone else’s promise.
Is it risky to buy NAD+ or NMN from a research-chemical site? Yes, and this is the risk that’s actually in your control. Those products are labeled “for research use only,” which is the legal condition they’re sold under, not a technicality. Dose yourself with one and you’re outside that legal lane with no clinician, no prescription, and no independent check on purity. Given how uncertain the benefit already is, that’s a lot of risk to take on for an unproven payoff. A supervised route with a prescriber and a licensed pharmacy is the safer structure if you’re doing this at all.
Is NMN legal to sell as a supplement in the US now? Yes. In letters dated September 29, 2025 the FDA concluded NMN is not excluded from the dietary-supplement definition, reversing its 2022 stance, so it can be legally sold as a supplement while still counting as a new dietary ingredient subject to premarket notification. That’s a legal status, not a safety or efficacy endorsement. Neither NMN nor NAD+ is approved as an anti-aging drug.
Does NMN actually get converted into NAD+ in your cells, or does most of it break down before it gets there?
It does convert, but the route is a little indirect. Some NMN turns into nicotinamide riboside (NR) in the gut before it’s even absorbed, and some enters cells directly through a transporter called Slc12a8. Human trials show oral NMN does raise blood NAD+ levels. How much actually reaches specific tissues like muscle or brain is still being worked out.
Does it matter if I take NMN in the morning versus at night?
Probably less than sticking to a routine does. Some researchers think morning dosing lines up better with the body’s natural NAD+ rhythm, but no well-powered human trial has actually compared morning versus evening and found a real winner. Until that study exists, just pick a time you’ll actually remember to take it.
Can you take NAD+ precursors alongside other medications, or are there real interaction risks?
Yes, there are real things to consider here, not just theoretical ones. NAD+ precursors affect sirtuin and PARP activity, which ties into DNA repair pathways, and some oncologists have raised questions about combining these with certain cancer treatments. If you’re on blood thinners, statins, or anything metabolized by the liver, talk to a prescribing doctor before you start. This is exactly the kind of conversation a physician-supervised compounding pharmacy like FormBlends builds into intake, and it’s exactly the kind of conversation a research-chemical checkout can’t have with you at all.
Why do some NAD+ products cost ten times more than others, and does the price actually tell you anything about quality?
Price can reflect manufacturing standards, third-party testing, and sourcing, but a high number on its own guarantees nothing. This market is largely unregulated for purity and potency, so two products with identical labels can have very different amounts of actual active compound inside. A certificate of analysis from an independent lab tells you more than the price does. Ask for one before you trust either.
References
- NMN 250 mg per day for 10 weeks increased muscle insulin sensitivity and insulin signaling in prediabetic postmenopausal women (n=25, randomized, placebo-controlled). Science, 2021. https://pubmed.ncbi.nlm.nih.gov/33888596/
- NMN supplementation enhanced several measures of aerobic capacity in amateur runners in a randomized, double-blind study, though VO2max did not change. Journal of the International Society of Sports Nutrition, 2021. https://pubmed.ncbi.nlm.nih.gov/34238308/
- Chronic supplementation with the NAD+ precursor nicotinamide riboside was well tolerated and elevated NAD+ in healthy middle-aged and older adults. Nature Communications, 2018.
- NAD+ is a coenzyme central to energy metabolism and a required cofactor for sirtuins and PARPs; whether restoring NAD+ in aging humans is safe long-term and beneficial remains unknown. Nature Reviews Molecular Cell Biology, 2021.
- NAD+ levels measured in human tissue across ages (newborn to 77) showed a strong negative correlation with age in both sexes. PLoS One, 2012.
- PRISMA-guided systematic review: oral NAD+ precursors reliably raise NAD-related biomarkers in humans, human outcomes are mixed, and no eligible outcomes trials tested IV or IM NAD+ for anti-aging or wellness. Ageing Research Reviews, 2026.
- FDA, in letters dated September 29, 2025, concluded NMN is not excluded from the dietary-supplement definition, reversing its 2022 position. NutraIngredients, Sept 30, 2025.
